http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2613031-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93448ce360e51f20db69ee58f8aee95e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2008-12-29^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-22^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3492aa928b25d2eb8938b3ac564d5cb7 |
| publicationDate | 2017-05-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2613031-T3 |
| titleOfInvention | Antiproliferative compounds and their use |
| abstract | Compound presenting a cellular antiproliferative activity, in which the compound comprises a conserved motif: (Res 1) - (Res 2) - (Res 3) - (Res 4) - (Res 5) - (Res 6) (Res 7 ) - (Res 8), in which Res 1- is selected from phenylalanine (F), alanine (A), and leucine (L); Res 2- is selected from glycine (G), and lysine (K); Res 3- is selected from glycine (G), asparagine (N), serine (S), leucine (10 L), and alanine (A); Res 4- is any natural amino acid; Res 5- is selected from leucine (L), isoleucine (I), and methionine (M); Res 6- is selected from serine (S), aspartic acid (D), and arginine (R); Res 7- is any natural amino acid; and Res 8- is selected from leucine (L), and isoleucine (I), and in which each of Res 1, Res 2, Res 3, Res 4, Res 5, Res 6, Res 7, and Res 8 they are covalently or non-covalently linked to the respective adjacent moiety, and in which the compound has less than 20 residues, for use in a method of treating a cell proliferative disorder in a subject. |
| priorityDate | 2007-12-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 997 of 997.